Pfizer and BioNTech expect to apply for approval from the U.S. Food and Drug Administration (FDA) for their coronavirus vaccine for use in children between the ages of 6 months and 5 years old in November, the company’s Chief Financial Officer Frank D’Amelio told an industry conference on Tuesday.

Pfizer had previously flagged that it planned to apply for U.S. approval for the jab for children between the ages of 5 and 11 in early October. Speaking at the Morgan Stanley Global Healthcare Conference, D’Amelio said the application for children aged between 6 months and 5 years would be filed “in the weeks shortly thereafter the filing of the data for the 5 to the 11 year-olds … assuming all of the data is positive,” according to Pfizer’s transcript of his comments.

The FDA approved the BioNTech/Pfizer vaccine in late August, making it the first COVID-19 vaccine to be fully licensed for use in the United States.

Both the BioNTech/Pfizer and the Moderna vaccines are authorized by the European Medicines Agency for children aged over 12 years.

Source link

Sign Up for Our Newsletters

Keep up to date and get notified on new posts!

You May Also Like

These Republicans torpedoed vaccine edicts — then slipped in the polls

564Views Then there’s the political calculus. Several Republican governors, including Abbott in…

Macron to use EU presidency to push for worldwide end of death penalty – POLITICO

539Views France is to use its upcoming presidency of the Council of…

Jilted France cancels events over lost submarine deal – POLITICO

464Views PARIS — Apoplectic. Blindsided. Jilted. Paris was a swirl of enraged…

China’s Xi pledges to end funding for overseas coal power plants

609Views China had been the subject of a pressure campaign by the…